Literature DB >> 7218595

Myocardial protection of only the left coronary artery perfusion in patients with isolated aortic valve replacement.

S Seki, M Tanizaki, K Hara, M Tago, K Fujita, S Teramoto.   

Abstract

Effectiveness of only left coronary perfusion on myocardial protection was assessed by measuring serially cardiac functions such as cardiac index (CI), stroke index (SI), left ventricular minute work index (LVWI) and left ventricular stroke work index (LVSWI) in 22 consecutive patients with isolated, scheduled aortic valve replacement. The cardiac functions were determined 2,4 and 6 hours after open heart surgery. Correlation coefficients(r) between coronary perfusion time and the cardiac functions were less than 0.23, such being statistically insignificant. SI and LVSWI were in statistically significant inverse correlation to the preoperative NYHA classification and extracorporeal circulation(ECC) time for 4 hours following open heart surgery, and CI and LVWI for 2 hours. The correlation coefficients were highest at the 2nd postoperative hour and then decreased with passage of time. Therefore, the cardiac dysfunctions occurring in the postoperative period correlated either to the preoperative NYHA classification or ECC time, or both. It does, however, seem likely that the dysfunctions were correlated to ECC time as the recovery time of 4 hours from the dysfunction is too short for preoperatively existing dysfunction. Therefore, it was concluded that the continuous perfusion of only the left coronary artery was not the determinant factor of the postoperative dysfunctions and that the ECC time afforded detrimental effects, although such continued for 4 hours in terms of SI and LVSWI, and 2 hours in term of CI and LVWI.

Entities:  

Mesh:

Year:  1980        PMID: 7218595     DOI: 10.1007/bf02468746

Source DB:  PubMed          Journal:  Jpn J Surg        ISSN: 0047-1909


  16 in total

1.  The superiority of aortic cross-clamping with profound local hypothermia for myocardial protection during aorta-coronary bypass grafting.

Authors:  R B Griepp; E B Stinson; P E Oyer; J G Copeland; N E Shumway
Journal:  J Thorac Cardiovasc Surg       Date:  1975-12       Impact factor: 5.209

2.  Myocardial preservation. Open discussion.

Authors: 
Journal:  J Thorac Cardiovasc Surg       Date:  1975-12       Impact factor: 5.209

3.  Elective cardiac arrest.

Authors:  D G MELROSE; B DREYER; H H BENTALL; J B BAKER
Journal:  Lancet       Date:  1955-07-02       Impact factor: 79.321

4.  Selective hypothermia of the heart in anoxic cardiac arrest.

Authors:  N E SHUMWAY; R R LOWER; R C STOFER
Journal:  Surg Gynecol Obstet       Date:  1959-12

Review 5.  Coronary artery perfusion.

Authors:  L L Michaelis
Journal:  Ann Thorac Surg       Date:  1975-07       Impact factor: 4.330

6.  Induced ischemic arrest. Clinical experience with cardioplegia in open-heart surgery.

Authors:  U Kirsch; G Rodewald; P Kalmár
Journal:  J Thorac Cardiovasc Surg       Date:  1972-01       Impact factor: 5.209

Review 7.  Myocardial resistance and tolerance to ischemia: physiological and biochemical basis.

Authors:  H J Bretschneider; G Hübner; D Knoll; B Lohr; H Nordbeck; P G Spieckermann
Journal:  J Cardiovasc Surg (Torino)       Date:  1975 May-Jun       Impact factor: 1.888

8.  Myocardial protection during aortic valve replacement.

Authors:  D G Mulder; G N Olinger; D H McConnell; J V Maloney; G D Buckberg
Journal:  Ann Thorac Surg       Date:  1976-02       Impact factor: 4.330

9.  Long-term morphologic and hemodynamic evaluation of the left ventricle after cardiopulmonary bypass. A comparison of normothermic anoxic arrest, coronary artery perfusion, and profound topical cardiac hypothermia.

Authors:  W R Brody; B A Reitz; M J Andrews; W C Roberts; L L Michaelis
Journal:  J Thorac Cardiovasc Surg       Date:  1975-12       Impact factor: 5.209

10.  Contractile damage from reperfusion after transient ischemia in the dog.

Authors:  H J Smith; K M Kent; S E Epstein
Journal:  J Thorac Cardiovasc Surg       Date:  1978-03       Impact factor: 5.209

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.